Bioforce Nanosciences Holdings Income Statement (2019-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Operating items
Selling, General & Administrative (Quarter)	0.01M	0.01M	0.03M	0.01M	0.02M	0.01M	0.02M	0.01M	0.01M	0.01M	0.03M	0.01M	0.02M	0.02M	0.03M	0.02M	0.01M		0.01M	0.12M
Other Operating Expenses (Quarter)	0.11M	0.11M	0.01M	0.11M	0.11M	0.11M	0.11M	0.11M	0.11M	0.11M	0.11M	0.11M	0.11M	0.11M	0.11M	0.11M	0.11M		0.11M	0.14M
Operating Expenses (Quarter)	0.11M	0.12M	0.03M	0.12M	0.12M	0.11M	0.13M	0.11M	0.11M	0.11M	0.13M	0.11M	0.12M	0.12M	0.13M	0.12M	0.12M		0.12M	0.26M
Operating Income (Quarter)												-0.11M	-0.12M		-0.13M	-0.12M	-0.12M
EBIT (Quarter)												-0.11M	-0.12M		-0.13M	-0.12M	-0.12M		-0.12M	-0.26M
Non-operating items
Other Non Operating Income (Quarter)															-0.80M
Non Operating Income (Quarter)															-0.80M				0.02M	0.50M
Net income details
EBT (Quarter)												-0.13M	-0.13M		-0.13M	-0.12M	-0.12M		-0.12M	-0.26M
Profit After Tax (Quarter)	-0.11M	-0.12M	-0.13M	-0.12M	-0.12M	-0.11M	-0.13M	-0.11M	-0.11M	-0.11M	-0.13M	-0.11M	-0.12M	-0.12M	-0.94M	-0.12M	-0.12M		-0.10M	0.24M
Income from Continuing Operations (Quarter)												-0.13M	-0.13M		-0.13M	-0.12M	-0.12M		-0.12M	-0.26M
Consolidated Net Income (Quarter)												-0.13M	-0.13M		-0.13M	-0.12M	-0.12M		-0.12M	-0.26M
Income towards Parent Company (Quarter)												-0.13M	-0.13M		-0.13M	-0.12M	-0.12M		-0.12M	-0.26M
Net Income towards Common Stockholders (Quarter)											-0.13M	-0.11M	-0.12M		-0.94M	-0.12M	-0.12M		-0.10M	0.24M
Additional items
EPS (Basic) (Quarter)											0.00	0.00	0.00		-0.03	0.00	0.00		0.00	0.01
EPS (Diluted) (Quarter)											0.00	0.00	0.00		-0.03	0.00	0.00		0.00	0.01
Shares Outstanding (Quarter)	29.27M	29.27M		29.27M	29.27M	29.27M	29.27M	29.27M	29.27M	29.27M	29.27M	29.27M	29.27M	29.27M	32.25M	32.25M	33.52M	33.21M	33.52M	33.54M
Shares Outstanding (Diluted) (Quarter)	29.27M	29.27M	29.27M	29.27M	29.27M	29.27M	29.27M	29.27M	29.27M	29.27M	29.27M	29.27M	29.27M	29.27M	32.25M	33.52M	33.52M	33.21M	33.52M	33.54M
Shares Outstanding (Entity) (Quarter)	29.27M	29.27M	29.27M	29.27M	29.27M	29.27M	29.27M	29.27M	29.27M	29.27M	29.27M	29.27M	29.27M	29.27M	33.52M	33.52M	33.52M	33.52M	33.52M	33.55M
EBITDA (Quarter)												-0.11M	-0.12M		-0.13M	-0.12M	-0.12M		-0.12M	-0.26M
Interest Expenses (Quarter)							0.02M	0.01M	0.01M		0.02M	0.01M	0.01M	0.01M	0.00M			923.00		0.01M

Research Tools

Datasets

Plans

Developers

Bioforce Nanosciences Holdings BFNH Income Statement (2019-2026)

Research Tools

Datasets

Plans

Developers

Bioforce Nanosciences Holdings BFNH Income Statement (2019-2026)

Create an account

Sign In

Reset Password